The Journal of Immunology, Vol 155, Issue 4 1893-1902, Copyright © 1995 by American Association of Immunologists

ARTICLES

Glucocorticoids accelerate anti-T cell receptor-induced T cell growth

GJ Wiegers, MS Labeur, IE Stec, WE Klinkert, F Holsboer and JM Reul
Department of Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany.

To study steroid regulation of cell-mediated immunity, we used anti-TCR- stimulated rat splenic lymphocyte mitogenesis as our experimental paradigm. Surprisingly, we found that the principal glucocorticoid of the rat, corticosterone (CORT), potently enhanced anti-TCR-induced lymphocyte proliferation after 2 to 3 days in culture, followed by inhibited cell growth after 5 to 7 days. Thus, glucocorticoids appeared to accelerate anti-TCR-induced lymphocyte mitogenesis. This effect occurred at physiologic concentrations (50-1000 nM), which are known to be released in vivo after an immune challenge. Kinetic experiments showed that CORT had to be present within 60 min after the initiation of TCR activation to produce maximal enhancing effects; a delay of 2 h or more left CORT ineffective. The lymphocytes incubated with CORT may have an increased sensitivity to IL-2 because 1) CORT suppressed IL-2 production throughout the culture period, and 2) an anti-IL-2R mAb completely blocked both control and CORT-treated anti-TCR-induced lymphocyte proliferation. Although the IL-2R alpha- and beta-chain mRNA concentrations were not altered in CORT-treated splenocyte cultures, we observed by FACS analysis an increased expression of the IL-2R alpha- chain on CORT-treated TCR alpha beta + and CD4+ T cells after 48 to 72 h of culture, suggesting an increased sensitivity of these T cells to IL-2 during the phase of enhanced proliferation. These results demonstrate a clear distinction between the enhancing effects of glucocorticoids on anti-TCR-induced lymphocyte proliferation and their well known inhibitory actions. Thus, the present study expands the regulatory role of glucocorticoids in cellular immunity, adding a novel effective stimulatory component to their inhibitory properties.

This article has been cited by other articles:

				K. Viswanathan, C. Daugherty, and F. S. Dhabhar Stress as an endogenous adjuvant: augmentation of the immunization phase of cell-mediated immunity Int. Immunol., August 1, 2005; 17(8): 1059 - 1069. [Abstract] [Full Text] [PDF]

				P. Sterzer, G. J. Wiegers, and J. M. H. M. Reul Long-Term in Vivo Administration of Glucocorticoid Hormones Attenuates Their Capacity to Accelerate in Vitro Proliferation of Rat Splenic T Cells Endocrinology, August 1, 2004; 145(8): 3630 - 3638. [Abstract] [Full Text] [PDF]

				F. S. DHABHAR Stress, Leukocyte Trafficking, and the Augmentation of Skin Immune Function Ann. N.Y. Acad. Sci., May 1, 2003; 992(1): 205 - 217. [Abstract] [Full Text] [PDF]

				F.-k. Kong, C.-l. H. Chen, and M. D. Cooper Reversible Disruption of Thymic Function by Steroid Treatment J. Immunol., June 15, 2002; 168(12): 6500 - 6505. [Abstract] [Full Text] [PDF]

				O. Lechner, H. Dietrich, G. J. Wiegers, M. Vacchio, and G. Wick Glucocorticoid production in the chicken bursa and thymus Int. Immunol., June 1, 2001; 13(6): 769 - 776. [Abstract] [Full Text] [PDF]

				G. J. Wiegers, I. E. M. Stec, W. E. F. Klinkert, and J. M. H. M. Reul Glucocorticoids Regulate TCR-Induced Elevation of CD4: Functional Implications J. Immunol., June 15, 2000; 164(12): 6213 - 6220. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				A. Stefferl, C. Linington, F. Holsboer, and J. M. H. M. Reul Susceptibility and Resistance to Experimental Allergic Encephalomyelitis: Relationship with Hypothalamic-Pituitary-Adrenocortical Axis Responsiveness in the Rat Endocrinology, November 1, 1999; 140(11): 4932 - 4938. [Abstract] [Full Text]

				J. D. Milner, S. C. Kent, T. A. Ashley, S. B. Wilson, J. L. Strominger, and D. A. Hafler Differential Responses of Invariant V{alpha}24J{alpha}Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone J. Immunol., September 1, 1999; 163(5): 2522 - 2529. [Abstract] [Full Text] [PDF]

				I. M. Dozmorov and R. A. Miller Generation of Antigen-Specific Th2 Cells from Unprimed Mice In Vitro: Effects of Dexamethasone and Anti-IL-10 Antibody J. Immunol., March 15, 1998; 160(6): 2700 - 2705. [Abstract] [Full Text] [PDF]

				A. C. E. Linthorst, C. Flachskamm, S. J. Hopkins, M. E. Hoadley, MartaS. Labeur, F. Holsboer, and J. M. H. M. Reul Long-Term Intracerebroventricular Infusion of Corticotropin-Releasing Hormone Alters Neuroendocrine, Neurochemical, Autonomic, Behavioral, and Cytokine Responses to a Systemic Inflammatory Challenge J. Neurosci., June 1, 1997; 17(11): 4448 - 4460. [Abstract] [Full Text] [PDF]

				F. S. Dhabhar, A. R. Satoskar, H. Bluethmann, J. R. David, and B. S. McEwen Stress-induced enhancement of skin immune function: A role for gamma interferon PNAS, March 14, 2000; 97(6): 2846 - 2851. [Abstract] [Full Text] [PDF]